A deal to buy biotechnology company Juno Therapeutics would further boost Celgene in the market for drugs treating multiple myeloma and other blood cancershttp://on.wsj.com/2EMblfP
2 replies
32 retweets
41 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.